Naturativ Sp. z o.o. announced a private placement of 150 common shares at an issue price of PLN 3,333 per share for the gross proceeds PLN 499,950 in funding on August 18, 2022. The transaction included participation from returning investor, Inno-Gene S.A. for 19.37% stake in the company.

Post closing of the transaction, the investor will hold 26.53% stake in the company.